If you need more lookups,
subscriptions start at $34 USD/month.
Michael Riedel Location
Cologne, NRW, DE
Michael Riedel Work
Head of Business Development Specialized Modalities, EMEA and APAC @ (June 2025 - Present)
Director Business Development @ (March 2022 - June 2025)
Associate Director Business Development @ (November 2021 - March 2022)
Senior Manager Business Development @ (September 2020 - November 2021)
Customer Proposals Manager @ (January 2018 - September 2020)
Project Manager @ (May 2017 - May 2018)
Project Manager @ (May 2015 - May 2017)
Research Scientist II @ (July 2013 - May 2015)
Postdoctoral Fellow @ (January 2010 - July 2013)
Manager Stem and iPS Cell Facility @ (July 2010 - June 2013)
Postdoctoral Fellow @ (January 2010 - July 2010)
PhD Student @ (June 2006 - December 2009)
Michael Riedel Education
University of Oldenburg
PhD (Neuroscience)
2006-2010
Michael Riedel Skills
Stem Cells
Clinical Research
Clinical Trial Management
Clinical Trials
Hospitals
Cell Therapy
Clinical Data Management
Cardiovascular Medicine
Clinical Monitoring
Budget Negotiation
Regulatory Affairs
Cell Biology
Developmental Biology
Regenerative Medicine
Cell Based Assays
Tissue Engineering
Cell
Medicine
CTMS
Biochemistry
Cell Culture
Immunohistochemistry
Lifesciences
Animal Models
Molecular Biology
Fluorescence Microscopy
Flow Cytometry
Tissue Culture
Biotechnology
Life Sciences
Sales
Microsoft Word
Research
Customer Service
Leadership
PowerPoint
Clinical Trial
Michael Riedel Summary
Michael Riedel, based in Cologne, NRW, DE, is currently a Head of Business Development Specialized Modalities, EMEA and APAC at Lonza. Michael Riedel brings experience from previous roles at Lonza. Michael Riedel holds a 2006 - 2010 PhD in Neuroscience @ University of Oldenburg. With a robust skill set that includes Stem Cells, Clinical Research, Clinical Trial Management, Clinical Trials, Hospitals and more. Michael Riedel has 2 emails and 3 mobile phone numbers on RocketReach.
Looking for a different Michael Riedel?
Find contact details for 700 million professionals.